Collagenase and surgical disease

Hernia

Volumn 10, Issue 6, 2006, Pages 478-485

  Donahue, Timothy R ^a   Hiatt, Jonathan R ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aneurysm; Collagenase; Hernia; Matrix metalloproteinase; Wound healing

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 14; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 7; COLLAGEN TYPE 8; COLLAGEN TYPE 9; COLLAGENASE; COLLAGENASE 3; DOXYCYCLINE; ELASTASE; ELASTIN; EPIDERMAL GROWTH FACTOR; FIBRILLIN 1; FIBRONECTIN; GELATINASE A; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; OSTEONECTIN; PLATELET DERIVED GROWTH FACTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ABDOMINAL AORTA ANEURYSM; ANEURYSM SURGERY; AORTA ANEURYSM; ARTHROPATHY; CANCER INVASION; CLINICAL TRIAL; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; HERNIA; HERNIOPLASTY; HUMAN; METASTASIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RECURRENCE RISK; REVIEW; RISK FACTOR; WOUND HEALING IMPAIRMENT;

ANIMALS; COLLAGEN; COLLAGENASES; DISEASE PROGRESSION; HERNIA; HUMANS; WOUND HEALING;

EID: 33751544125     PISSN: 12654906     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10029-006-0146-7     Document Type: Review

References (81)

1. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2(9):657-672
2. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161-174
3. Gorogh T, Beier UH, Baumken J, Meyer JE, Hoffmann M, Gottschlich S, Maune S (2006) Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck 28(1):31-39
4. Malemud CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: An overview. Front Biosci 11:1696-1701
5. Ala-aho R, Kahari VM (2005) Collagenases in cancer. Biochimie 87(3-4):273-286
6. Baker AH, Edwards DR, Murphy G (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115(Pt 19):3719-3727
7. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477(1-2):267-283
8. DeClerck YA, Yean TD, Lee Y, Tomich JM, Langley KE (1993) Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochem J 289(Pt 1):65-69
9. Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242(1):201-210
10. Saarialho-Kere UK (1998) Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 290(Suppl):S47-S54
11. Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P, Lauharanta J, Saarialho-Kere UK (1996) Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 135(1):52-59
12. Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53(4):288-295
13. Lobmann R, Schultz G, Lehnert H (2005) Proteases and the diabetic foot syndrome: Mechanisms and therapeutic implications. Diabetes Care 28(2):461-471
14. Wirl G, Frick J (1979) Collagenase - A marker enzyme in human bladder cancer? Urol Res 7(2):103-108
15. McGowan KA, Bauer EA, Smith LT (1994) Localization of type I human skin collagenase in developing embryonic and fetal skin. J Invest Dermatol 102(6):951-957
16. Ravanti L, Kahari VM (2000) Matrix metalloproteinases in wound repair (review). Int J Mol Med 6(4):391-407
17. Hasty KA, Hibbs MS, Kang AH, Mainardi CL (1986) Secreted forms of human neutrophil collagenase. J Biol Chem 261(12):5645-5650
18. Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL (1990) Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265(20):11421-11424
19. Cole AA, Chubinskaya S, Schumacher B, Huch K, Szabo G, Yao J, Mikecz K, Hasty KA, Kuettner KE (1996) Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 271(18):11023-11026
20. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Ronka H, Tschesche H, Salo T (1997) Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 272(50):31504-31509
21. Prikk K, Maisi P, Pirila E, Sepper R, Salo T, Wahlgren J, Sorsa T (2001) In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. J Pathol 194(2):232-238
22. Gross J, Lapiere CM (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 48(6):1014-1022
23. Knauper V, Cowell S, Smith B Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272(12):7608-7616
24. Ashworth JL, Murphy G, Rock MJ, Sherratt MJ, Shapiro SD, Shuttleworth CA, Kielty CM (1999) Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J 340(Pt 1):171-181
25. Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380(1-2):17-20
26. Thompson RW (2002) Reflections on the pathogenesis of abdominal aortic aneurysms. Cardiovasc Surg 10(4):389-394
27. Dobrin PB, Mrkvicka R (1994) Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2(4):484-488
28. Busuttil RW, Abou-Zamzam AM, Machleder HI (1980) Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms. Arch Surg 115(11):1373-1378
29. Busuttil RW, Rinderbriecht H, Flesher A, Carmack C (1982) Elastase activity: The role of elastase in aortic aneurysm formation. J Surg Res 32(3):214-217
30. Webster MW, McAuley CE, Steed DL, Miller DD, Evans CH (1991) Collagen stability and collagenolytic activity in the normal and aneurysmal human abdominal aorta. Am J Surg 161(6):635-638
31. Menashi S, Campa JS, Greenhalgh RM, Powell JT (1987) Collagen in abdominal aortic aneurysm: Typing, content, and degradation. J Vasc Surg 6(6):578-582
32. Zarins CK, Runyon-Hass A, Zatina MA, Lu CT, Glagov S (1986) Increased collagenase activity in early aneurysmal dilatation. J Vasc Surg 3(2):238-248
33. Vine N, Powell JT (1991) Metalloproteinases in degenerative aortic disease. Clin Sci (Lond) 81(2):233-239
34. Irizarry E, Newman KM, Gandhi RH, Nackman GB, Halpern V, Wishner S, Scholes JV, Tilson MD (1993) Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res 54(6):571-574
35. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15(8):1145-1151
36. Knox JB, Sukhova GK, Whittemore AD, Libby P (1997) Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95(1):205-212
37. Mao D, Lee JK, VanVickle SJ, Thompson RW (1999) Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem Biophys Res Commun 261(3):904-910
38. Panek B, Gacko M, Palka J (2004) Metalloproteinases, insulin-like growth factor-I and its binding proteins in aortic aneurysm. Int J Exp Pathol 85(3):159-164
39. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341(10):738-746
40. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL (1996) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87(4):709-719
41. Parks WC (1999) Matrix metalloproteinases in repair. Wound Repair Regen 7(6):423-432
42. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 137(6):1445-1457
43. Inoue M, Kratz G, Haegerstrand A, Stahle-Backdahl M (1995) Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol 104(4):479-483
44. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kahari VM, Saarialho-Kere U (1997) Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 109(1):96-101
45. Kahari VM, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6(5):199-213
46. Welgus HG, Jeffrey JJ, Eisen AZ (1981) The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem 256(18):9511-9515
47. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269(24):16766-16773
48. Le AD, Zhang Q, Wu Y, Messadi DV, Akhondzadeh A, Nguyen AL, Aghaloo TL, Kelly AP, Bertolami CN (2004) Elevated vascular endothelial growth factor in keloids: Relevance to tissue fibrosis. Cells Tissues Organs 176(1-3):87-94
49. Neely AN, Clendening CE, Gardner J, Greenhalgh DG, Warden GD (1999) Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen 7(3):166-171
50. Arakawa M, Hatamochi A, Mori Y, Mori K, Ueki H, Moriguchi T (1996) Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue. Br J Dermatol 134(5):863-868
51. Uchida G, Yoshimura K, Kitano Y, Okazaki M, Harii K (2003) Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts. Exp Dermatol 12(Suppl 2):35-42
52. Fujiwara M, Muragaki Y, Ooshima A (2005) Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 153(2):295-300
53. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW (1995) Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104(2):236-240
54. Vaalamo M, Leivo T, Saarialho-Kere U (1999) Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 30(7):795-802
55. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G (1999) Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair Regen 7(6):442-452
56. Armstrong DG, Jude EB (2002) The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 92(1):12-18
57. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L (2002) Mechanism of action of Promogran, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 10(1):16-25
58. Veves A, Sheehan P, Pham HT (2002) A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137(7):822-827
59. Vin F, Teot L, Meaume S (2002) The healing properties of Promogran in venous leg ulcers. J Wound Care 11(9):335-341
60. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516
61. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120(3):303-313
62. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 18(5):1135-1149
63. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149(1):273-282
64. Moilanen M, Pirila E, Grenman R, Sorsa T, Salo T (2002) Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol 197(1):72-81
65. Stadelmann WK, Digenis AG, Tobin GR (1998) Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 176(2A Suppl):26S-38S
66. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kahari VM (1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151(2):499-508
67. Cazorla M, Hernandez L, Nadal A, Balbin M, Lopez JM, Vizoso F, Fernandez PL, Iwata K, Cardesa A, Lopez-Otin C, Campo E (1998) Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 186(2):144-150
68. Yamamoto A, Yano S, Shiraga M, Ogawa H, Goto H, Miki T, Zhang H, Sone S (2003) A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice. Int J Cancer 103(6):822-828
69. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, Jesty J (1998) Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 75(5):780-786
70. Libby P, Aikawa M (2002) Stabilization of atherosclerotic plaques: New mechanisms and clinical targets. Nat Med 8(11):1257-1262
71. Rutkow IM, Robbins AW (1993) Demographic, classificatory, and socioeconomic aspects of hernia repair in the United States. Surg Clin North Am 73(3):413-426
72. Tilstra DJ, Byers PH (1994) Molecular basis of hereditary disorders of connective tissue. Annu Rev Med 45:149-163
73. Krieg T, Hein R, Hatamochi A, Aumailley M (1988) Molecular and clinical aspects of connective tissue. Eur J Clin Invest 18(2):105-123
74. Lehnert B, Wadouh F (1992) High coincidence of inguinal hernias and abdominal aortic aneurysms. Ann Vasc Surg 6(2):134-137
75. Zheng H, Si Z, Kasperk R, Bhardwaj RS, Schumpelick V, Klinge U, Klosterhalfen B (2002) Recurrent inguinal hernia: Disease of the collagen matrix? World J Surg 26(4):401-408
76. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2000) Abnormal collagen I to III distribution in the skin of patients with incisional hernia. Eur Surg Res 32(1):43-48
77. Rosch R, Klinge U, Si Z, Junge K, Klosterhalfen B, Schumpelick V (2002) A role for the collagen I/III and MMP-1/-13 genes in primary inguinal hernia? BMC Med Genet 3:2
78. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2001) Collagen I/III and matrix metalloproteinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg 14(1):47-54
79. Klinge U, Zheng H, Si ZY, Schumpelick V, Bhardwaj R, Klosterhalfen B (1999) Synthesis of type I and III collagen, expression of fibronectin and matrix metalloproteinases-1 and -13 in hernial sac of patients with inguinal hernia. Int J Surg Investig 1(3):219-227
80. Klinge U, Zheng H, Si Z, Schumpelick V, Bhardwaj RS, Muys L, Klosterhalfen B (1999) Expression of the extracellular matrix proteins collagen I, collagen III and fibronectin and matrix metalloproteinase-1 and -13 in the skin of patients with inguinal hernia. Eur Surg Res 31(6):480-490
81. Friedman DW, Boyd CD, Norton P, Greco RS, Boyarsky AH, Mackenzie JW, Deak SB (1993) Increases in type III collagen gene expression and protein synthesis in patients with inguinal hernias. Ann Surg 218(6):754-760